4 research outputs found
Characterization of a bean landrace from Sicily: the âfagiolo Badda di Polizzi'
Inside the project âPiano per la Produzione di Proteine Vegetali in Siciliaâ investigations were
carried out to characterize a bean population cultivated in the Parco delle Madonie area, the
âFagiolo Badda di Polizziâ. The producersâ interest for this landrace and the appreciation of the
consumers could justify the start up of a valorization program through a product certification.
Researches on the morpho-physiological aspects and on the nutritional profile were made in
trials conducted between 2005 and 2007. All the Badda bean accessions showed an indeterminate
plant growth habit, white flowers and a very delayed flowering time. In particular, a certain
variability was seen and described for the size and shape of pods and seeds. Two types of Badda
are cultivated, differentiated by the secondary seed colour: the âwhite Baddaâ and the âblack
Baddaâ. Both have ivory has a primary seed coat colour, but the âwhite Baddaâ has a brownish spot
on the hilum, whereas the âblack Baddaâ shows a black spot. In addition, the secondary colour of
the seed coat of the âblack Baddaâ showed two different pigmentations: violet and black, that
suggested a genetic differentiation into different sub-populations. Finally, the âblack Baddaâ
resulted less susceptible to viral infections than the âwhiteâ one.
At the molecular level, three accessions of Badda bean (two âwhiteâ and one âblackâ) have
been compared with control varieties, including one accessions of âFagiolo del Purgatorioâ from
Gradoli (VT), seven landraces of the Borlotto type collected in the Marche region and the cultivars
Bat, Jalo, Clio and Big Borlotto. The analyses were carried out using 12 Inter Simple Sequence
Repeats (ISSR) primers yielding a total of 140 bands. Although no specific band for the Badda
landrace were detected, two amplicons were found only in the accessions of Badda and in
Monachello, a bicol-seeded type from the Marche region, morphologically similar to the âblack
Baddaâ. The dendrogram obtained from the genetic distances based on ISSRs indicated that the
Badda type belongs to the Andean gene pool and that it is distinguishable from the tested controls
being grouped into a separate cluster. Within the Badda type, the âwhiteâ accessions were not
separated from the âblackâ one
The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters
Background: This observational retrospective study aimed to define the kinetics of serum levels of anti-SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) spike trimeric and anti-receptor binding domain (RBD) IgG antibodies up to 6 months after BNT162b2 vaccination. Methods: The sample consisted of 86 SARS-CoV-2 baseline seronegative subjects (median age 45 years, IQR 31-53 years; 52.3% females) undergoing vaccination with Pfizer/BioNTech BNT162b2. Blood was drawn before receiving the first and the second vaccine dose, as well as 1, 3 and 6 months after the second vaccine dose. The serum levels of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG antibodies were assayed. Results: The peak of both antibodies types was reached 1 month after the second dose (2808 and 2163 BAU/mL for anti-SARS-CoV-2 spike trimeric IgG and RBD IgG), after which serum levels progressively declined, falling after 6 months to 486 BAU/mL and 167 BAU/mL for anti-SARS-CoV-2 spike trimeric IgG and RBD IgG, respectively. The median rate of 6-month decline was 85% and 93% for anti-SARS-CoV-2 spike trimeric IgG and RBD IgG, respectively. The rate of vaccine recipients with serum antibodies levels above the 80% threshold of vaccine efficacy declined from over 95% at the peak to 72% and 5% at 6 months for anti-SARS-CoV-2 spike trimeric IgG and RBD IgG, respectively. Conclusions: The results of this retrospective observational study are consistent with the need for timely administration of vaccine boosters to prevent that humoral immunity will wane